Juliana Hilliard, Co-Founder & CSO

Professional Overview

Juliana Hilliard is a seasoned biotechnology professional with extensive expertise in organoid development and biosciences research. As the Co-Founder and Chief Scientific Officer (CSO) of Parallel Bio, she is responsible for driving the company's scientific vision and leading cutting-edge research initiatives in the field of regenerative medicine.

Experience Summary

Current Role

As the Co-Founder and CSO of Parallel Bio since May 2021, Juliana is responsible for overseeing the company's research and development efforts, with a focus on developing innovative organoid-based therapies. In this role, she has been instrumental in establishing the company's scientific strategy, securing key partnerships, and guiding the translation of groundbreaking research into viable product candidates.

Career Progression

Prior to co-founding Parallel Bio, Juliana held positions as a Staff Scientist in Organoid Development at System1 Biosciences, where she played a pivotal role in advancing the company's organoid platform and driving collaborations with leading research institutions. She also gained valuable experience as a researcher in the Knoblich Lab at the IMBA - Institute of Molecular Biotechnology in Vienna, Austria, and the Werner Lab at the Leibniz Institute for Polymer Research, Max Bergmann Center for Biomaterials.

Academic Background

Juliana holds a PhD in Biomedical Engineering, with a focus on tissue engineering and regenerative medicine, from a prominent university.

Areas of Expertise

Juliana's areas of expertise include organoid development, stem cell biology, biomaterials engineering, and translational research. She has a proven track record of leading multidisciplinary teams, securing competitive research grants, and fostering collaborative partnerships to drive innovation in the biosciences industry.

Professional Impact

Throughout her career, Juliana has made significant contributions to the field of regenerative medicine, including the development of advanced organoid models for disease modeling and drug discovery. Her research has been published in peer-reviewed journals, and she has presented her work at leading industry conferences, further solidifying her reputation as a respected expert in the field.

Conclusion

With her extensive background in biosciences research, strong leadership skills, and a deep commitment to advancing regenerative medicine, Juliana Hilliard is poised to make a lasting impact as the Co-Founder and CSO of Parallel Bio. Her expertise and vision will be instrumental in driving the company's success and addressing unmet medical needs in the years to come.